The role of N-Methyl-D-Aspartate (NMDA) receptor-mediated neurotransmission in the pathophysiology and therapeutics of psychiatric syndromes

By Heresco-Levy U.   Javitt D.C.  

European Neuropsychopharmacology, Vol. 8, Iss. 2, 1998-05 ,pp. : 141-152

Elsevier

Access to resources Recommend Favorite

Potential and Current Use of N -Methyl-D-Aspartate (NMDA) Receptor Antagonists in Diseases of Aging

By Le D.A.  

Drugs & Aging, Vol. 18, Iss. 10, 2001-10 ,pp. : 717-724

Adis International

Access to resources Recommend Favorite

The Glutamatergic Hypothesis for Down Syndrome: The Potential Use of N-Methyl-D-Aspartate Receptor Antagonists to Enhance Cognition and Decelerate Neurodegeneration

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 13, Iss. 1, 2014-01 ,pp. : 16-25

Bentham Science Publishers

Access to resources Recommend Favorite

A novel NMDA receptor antagonist protects against N-methyl-d-aspartate- and glutamate-induced neurotoxicity in the goldfish retina

By Tyan S.-H.   Sue T.-Y.   Hon Y.-S.   Gean P.-W.   Chang Y.-C.  

European Journal of Pharmacology, Vol. 321, Iss. 2, 1997-02 ,pp. : 171-179

Elsevier

Access to resources Recommend Favorite

Attention Deficit Hyperactivity Disorder and N-methyl-D-aspartate (NMDA) Dysregulation

By  

Current Pharmaceutical Design, Vol. 20, Iss. 32, 2014-10 ,pp. : 5180-5185

Bentham Science Publishers

Access to resources Recommend Favorite